Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NX1011 in Pulmonary Arterial Hypertension
NCT00323024Phase 2Withdrawn
- Sponsor
- Nitrox
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NX-1011 in pulmonary arterial hypertension (PAH), sponsored by Nitrox. Planned start Sep 2006; status: withdrawn.
02
Drugs
NX-1011
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00323024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323024.